1. Home
  2. BIO vs GKOS Comparison

BIO vs GKOS Comparison

Compare BIO & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIO
  • GKOS
  • Stock Information
  • Founded
  • BIO 1952
  • GKOS 1998
  • Country
  • BIO United States
  • GKOS United States
  • Employees
  • BIO N/A
  • GKOS N/A
  • Industry
  • BIO Biotechnology: Laboratory Analytical Instruments
  • GKOS Medical/Dental Instruments
  • Sector
  • BIO Industrials
  • GKOS Health Care
  • Exchange
  • BIO Nasdaq
  • GKOS Nasdaq
  • Market Cap
  • BIO 9.2B
  • GKOS 8.4B
  • IPO Year
  • BIO N/A
  • GKOS 2015
  • Fundamental
  • Price
  • BIO $223.99
  • GKOS $84.19
  • Analyst Decision
  • BIO Strong Buy
  • GKOS Strong Buy
  • Analyst Count
  • BIO 4
  • GKOS 13
  • Target Price
  • BIO $415.25
  • GKOS $161.54
  • AVG Volume (30 Days)
  • BIO 388.5K
  • GKOS 942.8K
  • Earning Date
  • BIO 05-06-2025
  • GKOS 04-30-2025
  • Dividend Yield
  • BIO N/A
  • GKOS N/A
  • EPS Growth
  • BIO N/A
  • GKOS N/A
  • EPS
  • BIO N/A
  • GKOS N/A
  • Revenue
  • BIO $2,566,500,000.00
  • GKOS $383,481,000.00
  • Revenue This Year
  • BIO $1.11
  • GKOS $27.84
  • Revenue Next Year
  • BIO $4.55
  • GKOS $27.99
  • P/E Ratio
  • BIO N/A
  • GKOS N/A
  • Revenue Growth
  • BIO N/A
  • GKOS 21.85
  • 52 Week Low
  • BIO $233.34
  • GKOS $86.74
  • 52 Week High
  • BIO $387.99
  • GKOS $163.71
  • Technical
  • Relative Strength Index (RSI)
  • BIO 30.82
  • GKOS 25.67
  • Support Level
  • BIO $235.84
  • GKOS $98.03
  • Resistance Level
  • BIO $248.00
  • GKOS $100.57
  • Average True Range (ATR)
  • BIO 7.49
  • GKOS 4.20
  • MACD
  • BIO 0.95
  • GKOS -0.38
  • Stochastic Oscillator
  • BIO 4.65
  • GKOS 3.57

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma. It offers iStent, a micro-bypass stent for insertion in conjunction with cataract surgery for the reduction of intraocular pressure in adult patients with mild-to-moderate open-angle glaucoma. Its product pipeline also consists of an iStent SA trabecular micro-bypass system, a two-stent product that is slightly wider than the iStent Inject and uses a different auto-injection inserter designed for use in a standalone procedure.

Share on Social Networks: